Catalyst Wire Dossier Catalyst Wire Dossier

Volenrelaxin

· Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Volenrelaxin, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease [Phase 2]

See pricing